Related Experiment Video
Updated: May 29, 2026
11:19
Correlating Gene-specific DNA Methylation Changes with Expression and Transcriptional Activity of Astrocytic KCNJ10 (Kir4.1)
Published on: September 26, 2015
Methylated-CpG Island Recovery Assay
Natalie Mitchell1, J Tyson Deangelis, Trygve O Tollefsbol
1Department of Biology, University of Alabama at Birmingham, Birmingham, AL, USA.
Methods in Molecular Biology (Clifton, N.J.)
|September 14, 2011
Summary
New DNA methylation analysis technology, Methylated-CpG Island Recovery Assay (MIRA), detects low-density methylation without bisulfite conversion. This advancement aids cancer research by enabling genome-wide epigenetic mark analysis.
Area of Science:
- Epigenetics
- Molecular Biology
- Cancer Research
Background:
- DNA methylation alterations are crucial in cancer development.
- Accurate analysis of epigenetic marks is essential for understanding cancer.
- Existing methods for DNA methylation analysis have limitations.
Purpose of the Study:
- To introduce a novel technology for analyzing DNA methylation.
- To enable detection of low-density methylation patterns.
- To provide a bisulfite-free method for genome-wide epigenetic analysis.
Main Methods:
- Methylated-CpG Island Recovery Assay (MIRA) utilizes the MBD2b/MDB3L1 complex.
- The MIRA technique binds to double-stranded methylated DNA.
- MIRA can detect single methylated CpG sites.
Main Results:
- MIRA allows recovery of methylated DNA without bisulfite conversion or antibody use.
- The assay is capable of detecting low-density methylation.
- MIRA can be integrated with microarrays and next-generation sequencing for genome-wide analysis.
Conclusions:
- MIRA offers a sensitive and efficient method for DNA methylation analysis.
- This technique advances the study of epigenetic alterations in cancer.
- MIRA provides a valuable tool for genome-wide epigenetic profiling.
